Horm Metab Res 2015; 47(07): 516-520
DOI: 10.1055/s-0034-1395608
Endocrine Research
© Georg Thieme Verlag KG Stuttgart · New York

Time-Course of Prednisone Effects on Hormonal and Inflammatory Responses at Rest and During Resistance Exercise

K. Collomp
1   Laboratoire CIAMS, Université Paris Sud – Université Orléans; Orléans, France
2   Département des Analyses, AFLD, Chatenay-Malabry, France
,
H. Zorgati
1   Laboratoire CIAMS, Université Paris Sud – Université Orléans; Orléans, France
,
F. Cottin
1   Laboratoire CIAMS, Université Paris Sud – Université Orléans; Orléans, France
,
M.-C. Do
1   Laboratoire CIAMS, Université Paris Sud – Université Orléans; Orléans, France
,
Z. Labsy
1   Laboratoire CIAMS, Université Paris Sud – Université Orléans; Orléans, France
,
O. Gagey
1   Laboratoire CIAMS, Université Paris Sud – Université Orléans; Orléans, France
,
F. Lasne
2   Département des Analyses, AFLD, Chatenay-Malabry, France
,
F. Prieur
1   Laboratoire CIAMS, Université Paris Sud – Université Orléans; Orléans, France
,
R. Collomp
3   Laboratoire de Soins Pharmaceutiques et de Santé Publique, Pôle Pharmacie, CHU, Nice, France
› Author Affiliations
Further Information

Publication History

received 22 July 2014

accepted 03 November 2014

Publication Date:
22 January 2015 (online)

Abstract

Glucocorticoids are among the most commonly used drugs. They are widely administered for acute and chronic musculoskeletal pain, as well as for several other pain syndromes, although their therapeutic use is sometimes diverted for doping purposes. Their time-course effects on hormonal and inflammatory responses nevertheless remain poorly understood, both at rest and during exercise. We therefore studied the alterations induced by 1 week of prednisone treatment (60 mg daily) in recreationally trained male athletes after 2 days (i. e., acute) and 7 days (i. e., short-term). Hormonal (i. e., DHEA, DHEA-S, aldosterone, and testosterone) and pro- and anti-inflammatory markers (i. e., IL-6, IL-10, and IL-1β) were investigated at rest and after resistance exercise. A significant decrease in DHEA and DHEA-S (p<0.01) without change in the DHEA/DHEA-S ratio, aldosterone, or testosterone was demonstrated after acute prednisone intake. A significant increment in IL-10 and a significant decrement in IL-6 (p<0.05) were also observed with prednisone both at rest and during exercise, without significant change in IL-1β. Continued prednisone treatment led to another significant decrease in both DHEA and DHEA-S (p<0.05), whereas no change in the inflammatory markers was observed between days 2 and 7. Our data demonstrate that the anti-inflammatory effects of prednisone were maximal and stable from the beginning of treatment, both in rest and exercise conditions. However, hormonal concentrations continued to decline during short-term intake. Further studies are needed to determine the effects of hormonal time-course alterations with longer glucocorticoid treatment and the clinical consequences.

 
  • References

  • 1 McMahon M, Gerich J, Rizza R. Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev 1988; 4: 17-30
  • 2 Markham A, Bryson HM. Deflazacort. A review of its pharmacological properties and therapeutic efficacy. Drugs 1995; 50: 317-333
  • 3 Hoes JN, Jacobs JW, Hulsmans HM, De Nijs RN, Lems WF, Bruyn GA, Geusens PP, Bijlsma JW. High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial. Clin Exp Rheumatol 2010; 28: 354-359
  • 4 Ciriaco M, Ventrice P, Russo G, Scicchitano M, Mazzitello G, Scicchitano F, Russo E. Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother 2013; 4 (Suppl. 01) S94-S98
  • 5 Yuen KC, Chong LE, Riddle MC. Influence of glucocorticoids and growth hormone on insulin sensitivity in humans. Diabet Med 2013; 30: 651-663
  • 6 Streck WF, Lockwood DH. Pituitary adrenal recovery following short-term suppression with corticosteroids. Am J Med 1979; 66: 910-914
  • 7 Carella MJ, Srivastava LS, Gossain VV, Rovner DR. Hypothalamic-pituitary-adrenal function one week after a short burst of steroid therapy. J Clin Endocrinol Metab 1993; 76: 1188-1191
  • 8 Watson AC, Rosenfield RL, Fang VS. Recovery from glucocorticoid inhibition of the responses to corticotrophin-releasing hormone. Clin Endocrinol 1988; 28: 471-475
  • 9 Spiegel RJ, Vigersky RA, Oliff AI, Echelberger CK, Bruton J, Poplack DG. Adrenal suppression after short-term corticosteroid therapy. Lancet 1979; 24: 630-633
  • 10 Zora JA, Zimmerman D, Carey TL, O’Connell EJ, Yunginger JW. Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol 1986; 77: 9-13
  • 11 Brigell D, Fang V, Rosenfeld RL. Recovery of responses to ovine corticotrophin-releasing hormone after withdrawal of a short course of glucocorticoid. J Clin Endocrinol Metab 1992; 74: 1036-1039
  • 12 Silva IN, Cunha CF, Finch FL, Colosimo EA. Evaluation of hypothalamic-pituitary-adrenal axis recovery after corticotherapy by using basal cortisol secretion. Arq Bras Endocrinol Metab 2006; 50: 118-124
  • 13 Jollin L, Thomasson R, Le Panse B, Baillot A, Vibarel-Rebot N, Lecoq AM, Amiot V, De Ceaurriz J, Collomp K. Saliva DHEA and cortisol responses following short-term corticosteroid intake. Eur J Clin Invest 2010; 40: 183-186
  • 14 Marquet P, Lac G, Chassain A, Habrioux G, Galen F. Dexamethasone in resting and exercising men. II. Effects on adrenocortical hormones. J Appl Physiol 1999; 87: 183-188
  • 15 Arlettaz A, Portier H, Lecoq AM, Rieth N, De Ceaurriz J, Collomp K. Effects of short-term prednisolone intake during submaximal exercise. Med Sci Sport Exerc 2007; 39: 1672-1678
  • 16 Collomp K, Arlettaz A, Portier H, Lecoq AM, Le Panse B, Rieth N De Ceaurriz Short term glucocorticoid intake combined with intense training on performance and hormonal responses. Br J Sports Med 2008; 42: 983-988
  • 17 Zorgati H, Prieur F, Vergniaud T, Cottin F, Do MC, Labsy Z, Amarantini D, Gagey O, Lasne F, Collomp K. Ergogenic and metabolic effects of oral glucocorticoid intake during repeated bouts of high-intensity exercise. Steroids 2014; 86: 10-15
  • 18 Deuster PA, Petrides JS, Singh A, Chrousos GP, Poth M. Endocrine response to high-intensity exercise: dose-dependent effects of dexamethasone. J Clin Endocrinol Metab 2000; 85: 1066-1073
  • 19 Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, Chrousos GP. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 1996; 271: E601-E605
  • 20 Arlettaz A, Collomp K, Portier H, Lecoq AM, Rieth N, Le Panse B, De Ceaurriz J. Effects of acute prednisolone administration on exercise endurance and metabolism. Br J Sports Med 2008; 42: 250-254
  • 21 Rentzos M, Nikolaou C, Rombos A, Evangelopoulos ME, Kararizou E, Koutsis G, Zoga M, Dimitrakopoulos A, Tsoutsou A, Sfangos C. Effect of treatment with methylprednisolone on the serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapse. Clin Neurol Neurosurg 2008; 110: 992-996
  • 22 De Jong EC, Vieira PL, Kalinski P, Kapsenberg ML. Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J Leukoc Biol 1999; 66: 201-204
  • 23 Kang BS, Chung EY, Yun YP, Lee MK, Lee YR, Lee KS, Min KR, Kim Y. Inhibitory effects of anti-inflammatory drugs on interleukin-6 bioactivity. Biol Pharm Bull 2001; 24: 701-703
  • 24 Brattsand R, Linden M. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther 1996; 10 (Suppl. 02) 81-92
  • 25 Swolin-Eide D, Ohlsson C. Effects of cortisol on the expression of interleukin-6 and interleukin-1 beta in human osteoblast-like cells. J Endocrinol 1998; 156: 107-114
  • 26 Yamazaki M, Aoshima K, Mizutani T, Ontachi Y, Saito M, Morishita E, Asakura H, Matsuda T, Triplett DA. Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats: importance of inflammatory cytokine suppression. Blood Coagul Fibrinolysis 1999; 10: 321-330
  • 27 Youssef PP, Haynes DR, Triantafillou S, Parker A, Gamble JR, Roberts-Thomson PJ, Ahern MJ, Smith MD. Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis. Arthritis Rheum 1997; 40: 1400-1408
  • 28 Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 1999; 515: 287-291
  • 29 Wang PT, Chiang IT, Lin CY, Hou CW, Chen CY, Lee HH, Chang WH, Kuo CH. Effect of a two-month detraining on glucose tolerance and insulin sensitivity in athletes – link to adrenal steroid hormones. Chin J Physiol 2006; 49: 251-257
  • 30 Barrett-Connor E. Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med 1992; 117: 807-811
  • 31 Kroboth PD, Salek FS, Pittenger AL, Fabian TJ Frye RF DHEA and DHEA-S: a review. J Clin Pharmacol 1999; 39: 327-348
  • 32 Ohlsson C, Labrie F, Barrett-Connor E, Karlsson MK, Ljunggren O, Vandenput L, Mellström D, Tivesten A. Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men. J Clin Endocrinol Metab 2010; 95: 4406-4414
  • 33 Traish AM, Kang HP, Saad F, Guay AT. Dehydroepiandrosterone (DHEA)-a precursor steroid or an active hormone in human physiology. J Sex Med 2011; 8: 2960-2982
  • 34 Jimenez MC, Sun Q, Schürks M, Chiuve S, Hu FB, Manson JE, Rexrode KM. Low dehydroepiandrosterone sulfate is associated with increased risk of ischemic stroke among women. Stroke 2013; 44: 1784-1789